MICROBEDX, INC.
UroLogic, a fully automated diagnostic instrument and cartridge system for rapid pathogen identification, quantification, and antimicrobial susceptibility testing from urine samples
- Sector
- Medtech
- Headquarters
- PACIFIC PALISADES, CA
- Founded
- 2015
- Latest Form D
- $507K, Oct 2021
- Total capital
- $7M
- Federal grants
- $300K
- 1 award · 2018
- Rank in peer group#12 of 542
- Private capital raised
- $6.7M
- 5 Form D · last Oct 2021
- 60 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 1 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$507K
- Private capital raisedForm D · SEC · 4th filing$300K
- Private capital raisedForm D · SEC · 3rd filing$3M
- Federal grantHealth and Human S · Phase I · UroLogic: Rapid, Near-to-Care Identification and Antimicrobial Susceptibility Testing of Microbes in Urine Specimens from Outpatients with Suspected Urinary Tract Infection$300K
- Private capital raisedForm D · SEC · 2nd filing$2.5M
- Private capital raisedForm D · SEC · 1st filing$400K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 542 peers
Line = medianMedtech · Device
- Federal grants#12 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Bernard M. ChurchillResearcherExecutive Officer, DirectorLinked by $300K in grants as PI
- Chuck M. BlevinExecutive OfficerNamed in SEC Form D filings
- Colin HalfordDirectorNamed in SEC Form D filings
- David M. HaakeExecutive Officer, DirectorNamed in SEC Form D filings
- James M. RatnerDirectorNamed in SEC Form D filings
- John HyshkaExecutive Officer, DirectorNamed in SEC Form D filings
Show all 10 people
- Maziar ZarrehparvarExecutive OfficerNamed in SEC Form D filings
- Michael ChurchillExecutive Officer, DirectorNamed in SEC Form D filings
- Richard JaneczkoExecutive Officer, DirectorNamed in SEC Form D filings
- Todd BartosDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 1- PendingRnase For Improved Microbial Detection And Antimicrobial Susceptibility TestingUSPTOApplication 62430785
Related companies, and why
- IRX REMINDER, LLCSimilar federal contract value in Medtech · null in contracts
- NANOCYTOMICS LLCSimilar federal contract value in Medtech · null in contracts
- Theracell, Inc.Similar federal contract value in Medtech · null in contracts
- DEEPWAVE TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
- Peltier Technology Inc.Similar federal contract value in Medtech · null in contracts
- Sonomotion Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .